Novavax asks EU regulator to clear COVID vaccine for teens
The pharmaceutical developer Novavax says it has asked the European Medicines Agency to extend the authorization of its coronavirus vaccine to children aged 12 to 17 amid a surge of disease across the continent.
Mar 31, 2022
0
2